CIBC World Market
TARA icon

CIBC World Market’s Protara Therapeutics TARA Stock Holding History

CIBC World Market’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636K Sell
166,495
-9,000
-5% -$42.8K ﹤0.01% 1146
2026
Q1 		$914K Sell
175,495
-53,400
-23% -$316K ﹤0.01% 966
2025
Q4 		$1.22M Sell
228,895
-46,099
-17% -$256K ﹤0.01% 883
2025
Q3 		$1.2M Sell
274,994
-16,500
-6% -$53.4K ﹤0.01% 894
2025
Q2 		$883K Buy
291,494
+55,884
+24% +$193K ﹤0.01% 917
2025
Q1 		$1M Buy
+235,610
New +$1.05M ﹤0.01% 877
2024
Q4 		– Sell
-28,000
Closed -$51K – 1444
2024
Q3 		$51K Sell
28,000
-9,000
-24% -$18.5K ﹤0.01% 1276
2024
Q2 		$77K Buy
+37,000
New +$108K ﹤0.01% 1229

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

CIBC World Market's TARA Position: Q2 2026 in Review

CIBC World Market reduced its Protara Therapeutics (TARA) stake by 5.1% in Q2 2026, selling an estimated $42.8K and leaving 166,495 shares worth $636K. The position accounts for ﹤0.01% of the portfolio, ranked #1146.

CIBC World Market first reported a position in TARA in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.22M in Q4 2025. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • CIBC World Market held 166,495 shares of Protara Therapeutics worth $636K as of Q2 2026.
  • CIBC World Market sold 9,000 Protara Therapeutics shares in Q2 2026, an estimated $42.8K.
  • Protara Therapeutics made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1146 holding.
  • CIBC World Market first reported a position in Protara Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • CIBC World Market's Protara Therapeutics position peaked at $1.22M in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.